Genetic Variation with MASLD Reveals Subtypes and Potential Therapeutic Avenues

Elizabeth Speliotes, MD, PhD, MPH, and teams found a better way to predict the individuals at highest risk for developing the disease, as well as provide direction for new therapeutics.